Inventor
SUH BYUNG-CHUL
US18 patents
⚠️ This page may combine multiple inventors who share the name “SUH BYUNG-CHUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
11 patentsUS10428070B2Oct 1, 2019
Hepatitis B antiviral agents
ENANTA PHARM INC24 citations94
US11596611B2Mar 7, 2023
Hepatitis B antiviral agents
ENANTA PHARM INC5 citations86
US10729688B2Aug 4, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC11 citations86
US10723733B2Jul 28, 2020
Hepatitis B antiviral agents
ENANTA PHARM INC13 citations86
US10952978B2Mar 23, 2021
Hepatitis B antiviral agents
ENANTA PHARM INC6 citations84
US12011425B2Jun 18, 2024
Hepatitis B antiviral agents
ENANTA PHARM INC1 citations73
US12496282B2Dec 16, 2025
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations62
US12398147B2Aug 26, 2025
Macrocyclic spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US11760755B2Sep 19, 2023
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US11472808B2Oct 18, 2022
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
US11236111B2Feb 1, 2022
Hepatitis B antiviral agents
ENANTA PHARM INC0 citations52
YUHAN CORP
4 patentsUS9593098B2Mar 14, 2017
Compounds and compositions for modulating EGFR mutant kinase activities
YUHAN CORP19 citations91
USRE50528EAug 12, 2025
Compounds and compositions for modulating EGFR mutant kinase activities
YUHAN CORP0 citations61
US11945798B2Apr 2, 2024
Substituted aminopyridine compounds as EGFR inhibitors
YUHAN CORP0 citations60
US12258327B2Mar 25, 2025
5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors
YUHAN CORP0 citations58